Company / SG&A per Share
Phio Pharmaceuticals Corp. SG&A per Share History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$7.03
FY2020
5-year range
$0.51 / $9.27
FY2016-FY2020
Trend
-24.1%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 7 years, ranging from $0.06 in FY2012 to $9.27 in FY2019.
Based on SEC 10-K filings.
7.03 in FY2020 with a 3-year CAGR of +36.2%.
Increased from $1.65 to $7.03 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +36.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, sg&a per share decreased 24.1% year-over-year.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $7.03 | -24.1% |
| FY2019 | $9.27 | +461.7% |
| FY2018 | $1.65 | -40.7% |
| FY2017 | $2.78 | +443.6% |
| FY2016 | $0.51 | +3.3% |
| FY2013 | $0.50 | +709.9% |
| FY2012 | $0.06 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026